Skip to main content
Top
Published in: Cancer Cell International 1/2013

Open Access 01-12-2013 | Primary research

Antiproliferative and apoptotic effects of β-elemene on human hepatoma HepG2 cells

Authors: Zhi-Jun Dai, Wei Tang, Wang-Feng Lu, Jie Gao, Hua-Feng Kang, Xiao-Bin Ma, Wei-Li Min, Xi-Jing Wang, Wen-Ying Wu

Published in: Cancer Cell International | Issue 1/2013

Login to get access

Abstract

Background

β-elemene, a natural sesquiterpene extracted from the essential oils of Curcuma aromatica Salisb, has been shown to be effective against a wide range of tumors. In this study, the antitumor effect of β-elemene on a human hepatoma cell line, HepG2, and the mechanism involved have been investigated.

Methods

MTT assay was used to determine the growth inhibition of hepatoma HepG2 cells in vitro. Apoptosis of HepG2 cells were demonstrated by fluorescence microscope with Hoechst 33258 staining and flow cytometry with Annexin V-FITC/PI double staining. Flow cytometry was performed to analyze the cell cycle distribution of HepG2 cells. The mRNA and protein expression of Fas and FasL were measured by RT-PCR and Western blot analysis.

Results

MTT results showed that β-elemene could inhibit the proliferation of HepG2 cells in a time- and dose- dependent manner. Our results showed β-elemene had positive effect on apoptosis through fluorescence microscope and flow cytometry assay. Furthermore, β-elemene could induce the cell cycle arrest of the HepG2 cells in the G2/M phase. Fas and FasL expression were obviously increased after β-elemene treatment in both mRNA and protein level.

Conclusion

The present study indicates that β-elemene can effectively inhibit proliferation and induce apoptosis in hepatoma HepG2 cells, and the apoptosis induction is related with up-regulating of Fas/FasL expression.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.CrossRefPubMed
2.
go back to reference Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M: Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol. 2011, 21: 401-416. 10.2188/jea.JE20100190.PubMedCentralCrossRefPubMed Tanaka M, Katayama F, Kato H, Tanaka H, Wang J, Qiao YL, Inoue M: Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol. 2011, 21: 401-416. 10.2188/jea.JE20100190.PubMedCentralCrossRefPubMed
3.
go back to reference Maluccio M, Covey A: Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012, 62: 394-399. 10.3322/caac.21161.CrossRefPubMed Maluccio M, Covey A: Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012, 62: 394-399. 10.3322/caac.21161.CrossRefPubMed
4.
go back to reference Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008, 359: 378-390. 10.1056/NEJMoa0708857.CrossRefPubMed Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group: Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008, 359: 378-390. 10.1056/NEJMoa0708857.CrossRefPubMed
5.
go back to reference Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z: Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009, 10: 25-34. 10.1016/S1470-2045(08)70285-7.CrossRefPubMed Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z: Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009, 10: 25-34. 10.1016/S1470-2045(08)70285-7.CrossRefPubMed
6.
go back to reference Cao H, Phan H, Yang LX: Improved chemotherapy for hepatocellular carcinoma. Anticancer Res. 2012, 32: 1379-1386.PubMed Cao H, Phan H, Yang LX: Improved chemotherapy for hepatocellular carcinoma. Anticancer Res. 2012, 32: 1379-1386.PubMed
7.
go back to reference Yu JQ, Liu HB, Lei JC, Tan WJ, Hu XM, Zou GL: Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res. 2007, 21: 817-822. 10.1002/ptr.2062.CrossRefPubMed Yu JQ, Liu HB, Lei JC, Tan WJ, Hu XM, Zou GL: Antitumor activity of chloroform fraction of Scutellaria barbata and its active constituents. Phytother Res. 2007, 21: 817-822. 10.1002/ptr.2062.CrossRefPubMed
8.
go back to reference Vickers A: Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest. 2002, 20: 1069-1079. 10.1081/CNV-120005926.CrossRefPubMed Vickers A: Botanical medicines for the treatment of cancer: rationale, overview of current data, and methodological considerations for phase I and II trials. Cancer Invest. 2002, 20: 1069-1079. 10.1081/CNV-120005926.CrossRefPubMed
9.
go back to reference Dai ZJ, Gao J, Li ZF, Ji ZZ, Kang HF, Guan HT, Diao Y, Wang BF, Wang XJ: In Vitro and In Vivo antitumor activity of Scutellaria Barbate extract on murine liver cancer. Molecules. 2011, 16: 4389-4400. 10.3390/molecules16064389.CrossRefPubMed Dai ZJ, Gao J, Li ZF, Ji ZZ, Kang HF, Guan HT, Diao Y, Wang BF, Wang XJ: In Vitro and In Vivo antitumor activity of Scutellaria Barbate extract on murine liver cancer. Molecules. 2011, 16: 4389-4400. 10.3390/molecules16064389.CrossRefPubMed
10.
go back to reference Yu ZH, Wei PK, Xu L, Qin ZF, Shi J: Anticancer effect of jinlongshe granules on in situ-transplanted human MKN-45 gastric cancer in nude mice and xenografted sarcoma 180 in Kunming mice and its mechanism. World J Gastroenterol. 2006, 12: 2890-2894.PubMedCentralPubMed Yu ZH, Wei PK, Xu L, Qin ZF, Shi J: Anticancer effect of jinlongshe granules on in situ-transplanted human MKN-45 gastric cancer in nude mice and xenografted sarcoma 180 in Kunming mice and its mechanism. World J Gastroenterol. 2006, 12: 2890-2894.PubMedCentralPubMed
11.
go back to reference Gupta S: Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int J Oncol. 2003, 22: 15-20.PubMed Gupta S: Molecular signaling in death receptor and mitochondrial pathways of apoptosis. Int J Oncol. 2003, 22: 15-20.PubMed
12.
go back to reference Liu F, Bardhan K, Yang D, Thangaraju M, Ganapathy V, Waller JL, Liles GB, Lee JR, Liu K: NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem. 2012, 287: 25530-25540. 10.1074/jbc.M112.356279.PubMedCentralCrossRefPubMed Liu F, Bardhan K, Yang D, Thangaraju M, Ganapathy V, Waller JL, Liles GB, Lee JR, Liu K: NF-κB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem. 2012, 287: 25530-25540. 10.1074/jbc.M112.356279.PubMedCentralCrossRefPubMed
13.
go back to reference Dai ZJ, Gao J, Ji ZZ, Wang XJ, Ren HT, Liu XX, Wu WY, Kang HF, Guan HT: Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol. 2009, 123: 91-96. 10.1016/j.jep.2009.02.022.CrossRefPubMed Dai ZJ, Gao J, Ji ZZ, Wang XJ, Ren HT, Liu XX, Wu WY, Kang HF, Guan HT: Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. J Ethnopharmacol. 2009, 123: 91-96. 10.1016/j.jep.2009.02.022.CrossRefPubMed
14.
go back to reference Lu JJ, Dang YY, Huang M, Xu WS, Chen XP, Wang YT: Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae. J Ethnopharmacol. 2012, 143: 406-411. 10.1016/j.jep.2012.07.009.CrossRefPubMed Lu JJ, Dang YY, Huang M, Xu WS, Chen XP, Wang YT: Anti-cancer properties of terpenoids isolated from Rhizoma Curcumae. J Ethnopharmacol. 2012, 143: 406-411. 10.1016/j.jep.2012.07.009.CrossRefPubMed
15.
go back to reference Zhang R, Tian A, Zhang H, Zhou Z, Yu H, Chen L: Amelioration of experimental autoimmune encephalomyelitis by beta-elemene treatment is associated with Th17 and Treg cell balance. J Molecular Neuroscience. 2011, 44: 31-40. 10.1007/s12031-010-9483-1.CrossRef Zhang R, Tian A, Zhang H, Zhou Z, Yu H, Chen L: Amelioration of experimental autoimmune encephalomyelitis by beta-elemene treatment is associated with Th17 and Treg cell balance. J Molecular Neuroscience. 2011, 44: 31-40. 10.1007/s12031-010-9483-1.CrossRef
16.
go back to reference Wang B, Peng XX, Sun R, Li J, Zhan XR, Wu LJ, Wang SL, Xie T: Systematic review of β-Elemene injection as adjunctive treatment for lung cancer. Chin J Integr Med. 2012, 18: 813-823. 10.1007/s11655-012-1271-9.CrossRefPubMed Wang B, Peng XX, Sun R, Li J, Zhan XR, Wu LJ, Wang SL, Xie T: Systematic review of β-Elemene injection as adjunctive treatment for lung cancer. Chin J Integr Med. 2012, 18: 813-823. 10.1007/s11655-012-1271-9.CrossRefPubMed
17.
go back to reference Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham C, Coad JE, Flynn DC, Reed E, Li QQ: Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci. 2005, 62: 881-893. 10.1007/s00018-005-5017-3.CrossRefPubMed Wang G, Li X, Huang F, Zhao J, Ding H, Cunningham C, Coad JE, Flynn DC, Reed E, Li QQ: Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death. Cell Mol Life Sci. 2005, 62: 881-893. 10.1007/s00018-005-5017-3.CrossRefPubMed
18.
go back to reference Zhang B, Zhang X, Tang B, Zheng P, Zhang Y: Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression. Breast Cancer Res Treat. 2012, 136: 399-406. 10.1007/s10549-012-2263-6.CrossRefPubMed Zhang B, Zhang X, Tang B, Zheng P, Zhang Y: Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor α (ERα) re-expression. Breast Cancer Res Treat. 2012, 136: 399-406. 10.1007/s10549-012-2263-6.CrossRefPubMed
19.
go back to reference Li QQ, Wang G, Huang F, Banda M, Reed E: Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells. J Pharm Pharmacol. 2010, 62: 1018-1027. 10.1111/j.2042-7158.2010.01135.x.CrossRefPubMed Li QQ, Wang G, Huang F, Banda M, Reed E: Antineoplastic effect of beta-elemene on prostate cancer cells and other types of solid tumour cells. J Pharm Pharmacol. 2010, 62: 1018-1027. 10.1111/j.2042-7158.2010.01135.x.CrossRefPubMed
20.
go back to reference Liu J, Zhang Y, Qu J, Xu L, Hou K, Zhang J, Qu X, Liu Y: β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer. 2011, 11: 183-10.1186/1471-2407-11-183.PubMedCentralCrossRefPubMed Liu J, Zhang Y, Qu J, Xu L, Hou K, Zhang J, Qu X, Liu Y: β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis. BMC Cancer. 2011, 11: 183-10.1186/1471-2407-11-183.PubMedCentralCrossRefPubMed
21.
go back to reference Li X, Wang G, Zhao J, Ding H, Cunningham C, Chen F, Flynn DC, Reed E, Li QQ: Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci. 2005, 62: 894-904. 10.1007/s00018-005-5027-1.CrossRefPubMed Li X, Wang G, Zhao J, Ding H, Cunningham C, Chen F, Flynn DC, Reed E, Li QQ: Antiproliferative effect of beta-elemene in chemoresistant ovarian carcinoma cells is mediated through arrest of the cell cycle at the G2-M phase. Cell Mol Life Sci. 2005, 62: 894-904. 10.1007/s00018-005-5027-1.CrossRefPubMed
22.
go back to reference Liang D, Yang M, Guo B, Yang L, Cao J, Zhang X: HIF-1α induced by β-elemene protects human osteosarcoma cells from undergoing apoptosis. J Cancer Res Clin Oncol. 2012, 138: 1865-1887. 10.1007/s00432-012-1256-5.CrossRefPubMed Liang D, Yang M, Guo B, Yang L, Cao J, Zhang X: HIF-1α induced by β-elemene protects human osteosarcoma cells from undergoing apoptosis. J Cancer Res Clin Oncol. 2012, 138: 1865-1887. 10.1007/s00432-012-1256-5.CrossRefPubMed
23.
go back to reference Dai ZJ, Ma XB, Kang HF, Gao J, Min WL, Guan HT, Diao Y, Lu WF, Wang XJ: Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in vitro and in vivo. Cancer Cell Int. 2012, 12: 53-10.1186/1475-2867-12-53.PubMedCentralCrossRefPubMed Dai ZJ, Ma XB, Kang HF, Gao J, Min WL, Guan HT, Diao Y, Lu WF, Wang XJ: Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in vitro and in vivo. Cancer Cell Int. 2012, 12: 53-10.1186/1475-2867-12-53.PubMedCentralCrossRefPubMed
24.
go back to reference Guan HT, Xue XH, Dai ZJ, Wang XJ, Li A, Qin ZY: Downregulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity. World J Gastroenterol. 2006, 12: 2901-2907.PubMedCentralPubMed Guan HT, Xue XH, Dai ZJ, Wang XJ, Li A, Qin ZY: Downregulation of survivin expression by small interfering RNA induces pancreatic cancer cell apoptosis and enhances its radiosensitivity. World J Gastroenterol. 2006, 12: 2901-2907.PubMedCentralPubMed
25.
go back to reference Tao L, Zhou L, Zheng L, Yao M: Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo. Cancer Chemother Pharmacol. 2006, 58: 24-34. 10.1007/s00280-005-0137-x.CrossRefPubMed Tao L, Zhou L, Zheng L, Yao M: Elemene displays anti-cancer ability on laryngeal cancer cells in vitro and in vivo. Cancer Chemother Pharmacol. 2006, 58: 24-34. 10.1007/s00280-005-0137-x.CrossRefPubMed
26.
go back to reference Bao F, Qiu J, Zhang H: Potential role of β-elemene on histone H1 in the H22 ascites hepatoma cell line. Mol Med Report. 2012, 6: 185-190. Bao F, Qiu J, Zhang H: Potential role of β-elemene on histone H1 in the H22 ascites hepatoma cell line. Mol Med Report. 2012, 6: 185-190.
27.
go back to reference Liu J, Zhang Z, Gao J, Xie J, Yang L, Hu S: Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis. Front Med. 2011, 5: 101-105. 10.1007/s11684-011-0111-4.CrossRefPubMed Liu J, Zhang Z, Gao J, Xie J, Yang L, Hu S: Downregulation effects of beta-elemene on the levels of plasma endotoxin, serum TNF-alpha, and hepatic CD14 expression in rats with liver fibrosis. Front Med. 2011, 5: 101-105. 10.1007/s11684-011-0111-4.CrossRefPubMed
28.
go back to reference Zhao YS, Zhu TZ, Chen YW, Yao YQ, Wu CM, Wei ZQ, Wang W, Xu YH: Β-elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells. J Neurooncol. 2012, 107: 307-314. 10.1007/s11060-011-0770-7.CrossRefPubMed Zhao YS, Zhu TZ, Chen YW, Yao YQ, Wu CM, Wei ZQ, Wang W, Xu YH: Β-elemene inhibits Hsp90/Raf-1 molecular complex inducing apoptosis of glioblastoma cells. J Neurooncol. 2012, 107: 307-314. 10.1007/s11060-011-0770-7.CrossRefPubMed
29.
go back to reference Lee RX, Li QQ, Reed E: β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells. Anticancer Res. 2012, 32: 3103-3113.PubMedCentralPubMed Lee RX, Li QQ, Reed E: β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells. Anticancer Res. 2012, 32: 3103-3113.PubMedCentralPubMed
30.
go back to reference Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ, Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett. 2008, 264: 127-134. 10.1016/j.canlet.2008.01.049.CrossRefPubMed Yao YQ, Ding X, Jia YC, Huang CX, Wang YZ, Xu YH: Anti-tumor effect of beta-elemene in glioblastoma cells depends on p38 MAPK activation. Cancer Lett. 2008, 264: 127-134. 10.1016/j.canlet.2008.01.049.CrossRefPubMed
31.
go back to reference Liu J, Hu XJ, Jin B, Qu XJ, Hou KZ, Liu YP: β-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells. J Pharm Pharmacol. 2012, 64: 146-153. 10.1111/j.2042-7158.2011.01371.x.CrossRefPubMed Liu J, Hu XJ, Jin B, Qu XJ, Hou KZ, Liu YP: β-Elemene induces apoptosis as well as protective autophagy in human non-small-cell lung cancer A549 cells. J Pharm Pharmacol. 2012, 64: 146-153. 10.1111/j.2042-7158.2011.01371.x.CrossRefPubMed
32.
go back to reference Pinti M, Troiano L, Nasi M, Moretti L, Monterastelli E, Mazzacani A, Mussi C, Ventura P, Olivieri F, Franceschi C, Salvioli G, Cossarizza A: Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians. Cell Death Differ. 2002, 9: 431-438. 10.1038/sj.cdd.4400964.CrossRefPubMed Pinti M, Troiano L, Nasi M, Moretti L, Monterastelli E, Mazzacani A, Mussi C, Ventura P, Olivieri F, Franceschi C, Salvioli G, Cossarizza A: Genetic polymorphisms of Fas (CD95) and FasL (CD178) in human longevity: studies on centenarians. Cell Death Differ. 2002, 9: 431-438. 10.1038/sj.cdd.4400964.CrossRefPubMed
33.
go back to reference Fumarola C, Guidotti GG: Stress-induced apoptosis: toward a symmetry with receptor mediated cell death. Apoptosis. 2004, 9: 77-82.CrossRefPubMed Fumarola C, Guidotti GG: Stress-induced apoptosis: toward a symmetry with receptor mediated cell death. Apoptosis. 2004, 9: 77-82.CrossRefPubMed
34.
go back to reference Zhao J, Li QQ, Zou B, Wang G, Li X, Kim JE, Cuff CF, Huang L, Reed E, Gardner K: In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma. Int J Oncol. 2007, 31: 241-252.PubMed Zhao J, Li QQ, Zou B, Wang G, Li X, Kim JE, Cuff CF, Huang L, Reed E, Gardner K: In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma. Int J Oncol. 2007, 31: 241-252.PubMed
Metadata
Title
Antiproliferative and apoptotic effects of β-elemene on human hepatoma HepG2 cells
Authors
Zhi-Jun Dai
Wei Tang
Wang-Feng Lu
Jie Gao
Hua-Feng Kang
Xiao-Bin Ma
Wei-Li Min
Xi-Jing Wang
Wen-Ying Wu
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2013
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-13-27

Other articles of this Issue 1/2013

Cancer Cell International 1/2013 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine